Robinson Esalimba – Notwithstanding the high regard one might have for a computer software engineer, it would be outrageous to consider commissioning one to design a drug for malaria, or even still, that the drug should be produced in a car manufacturing plant. Yet, it is precisely in this manner that most discussions on transfer of technology have carried on; as if what is good for the car is good enough for the drug. The proposed World Intellectual Property Organization (WIPO) Development Agenda project on Intellectual Property and Technology Transfer (CDIP/4/7), which is up for discussion at the fifth session of the Committee on Development and Intellectual Property (CDIP) in April 2010, has the opportunity to change this thinking, but only if it redefines the problem that it seeks to solve. In this post and in Part II, I propose how this can be done.  Read the rest of this entry »